| Nov 7 |
Rafael Holdings GAAP EPS of -$0.19, revenue of $0.17M
|
| Nov 7 |
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
|
| Sep 16 |
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
|
| Aug 22 |
Cyclo Therapeutics falls after merger agreement with Rafael Holdings
|
| Aug 22 |
Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
|
| Jun 19 |
Rafael Holdings Third Quarter 2024 Earnings: US$1.36 loss per share (vs US$0.061 loss in 3Q 2023)
|
| Jun 14 |
Rafael Holdings GAAP EPS of -$1.36, revenue of $0.34M
|
| Jun 14 |
Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
|
| May 30 |
Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
|
